Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Net Cash Flow (2018 - 2026)

DiaMedica Therapeutics filings provide 9 years of Net Cash Flow readings, the most recent being -$10.8 million for Q1 2026.

  • Quarterly Net Cash Flow fell 2376.38% to -$10.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Mar 2026, up 359.55% year-over-year, with the annual reading at $12.6 million for FY2025, 931.49% up from the prior year.
  • Net Cash Flow hit -$10.8 million in Q1 2026 for DiaMedica Therapeutics, down from $12.3 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $12.3 million in Q4 2025 and bottomed at -$10.8 million in Q1 2026.
  • Average Net Cash Flow over 5 years is $8411.8, with a median of -$436000.0 recorded in 2025.
  • The largest annual shift saw Net Cash Flow surged 12206.67% in 2023 before it plummeted 2376.38% in 2026.
  • DiaMedica Therapeutics' Net Cash Flow stood at $2.0 million in 2022, then rose by 18.09% to $2.3 million in 2023, then plummeted by 147.99% to -$1.1 million in 2024, then surged by 1211.27% to $12.3 million in 2025, then crashed by 187.61% to -$10.8 million in 2026.
  • Per Business Quant, the three most recent readings for DMAC's Net Cash Flow are -$10.8 million (Q1 2026), $12.3 million (Q4 2025), and -$833000.0 (Q3 2025).